EPAM acquires Odysseus Data Services to enhance life sciences solutions, revenue expected to decline
From Nasdaq: 2024-06-14 09:43:00
EPAM acquires Odysseus Data Services, Inc. to enhance life sciences solutions with analytics and AI capabilities. Current offerings include tools like New Genome Browser and MRI Viewer. Updates to Indigo, Bingo, and Ketcher tools released. Expectations for 2024 revenues show a decline, impacted by macroeconomic challenges and IT spending trends.
EPAM partners with Microsoft and Salesforce for AI capabilities. Launches DIAL Open Source and DIAL Orchestration Platforms. Facing a 40% decrease in share value, attributed to IT spending softening. First quarter 2024 revenues down 3.8% year-over-year. Company expects revenue decline for 2024. Investors advised to wait for a better entry point.
Zacks Investment Research releases a Special Report on 5 Dividend Stocks for retirement planning. Includes insights on property management, upscale outlets, financial institutions, and energy producers. Free download available. Partnered with Microsoft, Salesforce, IQVIA, Informatica, MicroStrategy, and MongoDB for data and AI solutions.EPAM continues to expand its footprint in the life sciences market. Acquires Odysseus Data Services to enhance life sciences value chain.Updates to tools like Indigo, Bingo, and Ketcher. Expectations for 2024 show revenue decline due to macroeconomic challenges and IT spending trends.
Read more at Nasdaq: EPAM Expands in Life Sciences Space With Odysseus Buyout